We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIS icon
8726
CALL
OSI Systems
OSIS
$3.79B
$461K ﹤0.01%
5,400
+2,800
+108% +$230K
POWA icon
8727
Invesco Bloomberg Pricing Power ETF
POWA
$180M
$461K ﹤0.01%
7,235
-1,986
-22% -$133K
WRLD icon
8728
World Acceptance Corp
WRLD
$886M
$461K ﹤0.01%
+4,106
New +$646K
AIV
8729
CALL
Aimco
AIV
$381M
$460K ﹤0.01%
71,900
+23,300
+48% +$147K
AMPY icon
8730
CALL
Amplify Energy
AMPY
$200M
$460K ﹤0.01%
70,300
-11,700
-14% -$86.3K
CRMD icon
8731
CorMedix
CRMD
$598M
$460K ﹤0.01%
114,357
+85,583
+297% +$318K
PBA icon
8732
CALL
Pembina Pipeline
PBA
$28.3B
$460K ﹤0.01%
13,000
+500
+4% +$19.3K
HTB
8733
HomeTrust Bancshares
HTB
$798M
$460K ﹤0.01%
18,386
-8,164
-31% -$221K
JKS
8734
JinkoSolar
JKS
$870M
$459K ﹤0.01%
6,631
-84,473
-93% -$4.74M
SPLV icon
8735
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.11B
$459K ﹤0.01%
7,400
-5,300
-42% -$343K
ADT icon
8736
PUT
ADT
ADT
$5.25B
$458K ﹤0.01%
74,400
-30,800
-29% -$215K
CLPT icon
8737
ClearPoint Neuro
CLPT
$473M
$458K ﹤0.01%
+35,117
New +$359K
GLP icon
8738
PUT
Global Partners
GLP
$1.72B
$458K ﹤0.01%
19,500
+8,600
+79% +$228K
SMPL icon
8739
PUT
Simply Good Foods
SMPL
$959M
$457K ﹤0.01%
+12,100
New +$479K
OKUR
8740
OnKure Therapeutics
OKUR
$166M
$457K ﹤0.01%
+17,259
New +$402K
SMR.WS
8741
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$457K ﹤0.01%
+225,101
New +$525K
MUDS
8742
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$457K ﹤0.01%
+45,307
New +$456K
BFAM icon
8743
CALL
Bright Horizons
BFAM
$3.7B
$456K ﹤0.01%
5,400
-14,900
-73% -$1.48M
CGAU
8744
Centerra Gold
CGAU
$4.29B
$456K ﹤0.01%
67,588
+32,988
+95% +$279K
LAKE icon
8745
CALL
Lakeland Industries
LAKE
$116M
$456K ﹤0.01%
29,700
+18,600
+168% +$316K
NEWT icon
8746
PUT
NewtekOne
NEWT
$371M
$456K ﹤0.01%
24,100
+7,400
+44% +$178K
SRS icon
8747
CALL
ProShares UltraShort Real Estate
SRS
$14M
$456K ﹤0.01%
+6,675
New +$407K
WWE
8748
PUT
DELISTED
World Wrestling Entertainment
WWE
$456K ﹤0.01%
7,300
-19,400
-73% -$1.2M
GLOP
8749
DELISTED
GASLOG PARTNERS LP
GLOP
$456K ﹤0.01%
82,136
+64,894
+376% +$356K
BIB icon
8750
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$90.1M
$455K ﹤0.01%
9,400
-4,900
-34% -$249K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.